Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,985 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
RNase T2 deficiency promotes TLR13-dependent replenishment of tissue-protective Kupffer cells.
Sato R, Liu K, Shibata T, Hoshino K, Yamaguchi K, Miyazaki T, Hiranuma R, Fukui R, Motoi Y, Fukuda-Ohta Y, Zhang Y, Reuter T, Ishida Y, Kondo T, Chiba T, Asahara H, Taoka M, Yamauchi Y, Isobe T, Kaisho T, Furukawa Y, Latz E, Nakatani K, Izumi Y, Nie Y, Taniguchi H, Miyake K. Sato R, et al. Among authors: taniguchi h. J Exp Med. 2025 Mar 3;222(3):e20230647. doi: 10.1084/jem.20230647. Epub 2025 Jan 24. J Exp Med. 2025. PMID: 39853307
Paclitaxel plus cetuximab versus nivolumab for patients with platinum-refractory recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis.
Kodama H, Kadowaki S, Ishizuka Y, Wakabayashi M, Sakakida T, Honda K, Masuishi T, Narita Y, Taniguchi H, Ando M, Kishikawa T, Terada H, Beppu S, Nishikawa D, Suzuki H, Hanai N, Muro K. Kodama H, et al. Among authors: taniguchi h. Int J Clin Oncol. 2025 Jan 14. doi: 10.1007/s10147-025-02698-1. Online ahead of print. Int J Clin Oncol. 2025. PMID: 39806030
Investigation of the association between therapeutic effectiveness of anamorelin and Glasgow prognostic score in patients with cancer cachexia: a competing risk analysis.
Shimomura K, Ogata T, Maeda A, Narita Y, Taniguchi H, Murotani K, Fujiwara Y, Tajika M, Hara K, Muro K, Uchida K. Shimomura K, et al. Among authors: taniguchi h. Invest New Drugs. 2025 Jan 9. doi: 10.1007/s10637-024-01503-6. Online ahead of print. Invest New Drugs. 2025. PMID: 39789368
2,985 results